PIK3CA-related Vascular Malformations (PRVM)

1

Review clinical trials related to PIK3CA-related Vascular Malformations (PRVM). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CYH33 in Patients With PIK3CA-related Overgrowth Spectrum (PROS) and PIK3CA-related Vascular Malformations (PRVM)

This study is a multi-center, open-label, single arm, phase I/II study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of CYH33 in patients with PIK3CA-related overgrowth spectrum (PROS) and PIK3CA-related vascular malformations (PRVM)

Participants needed: 141
Trial details
Phase: Phase 1, Phase 2Biological sex: AllType: InterventionalSponsor: Haihe Biopharma Co., Ltd.Updated: Jun 29, 2026Locations: 15
Eligibility criteria

The patient or the patient's legal guardian (if applicable) voluntarily signs th... [+3]

PROS patients presenting solely with isolated macrodactyly, epidermal nevi/nevus... [+2]